Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News

‘Stunning’ twincretin beats semaglutide for A1c, weight reduction in T2D
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 26, 2021
News

Medically suspect criterion can determine bariatric surgery coverage
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 18, 2021
News

Bariatric surgery cuts insulin needs in type 1 diabetes with severe obesity
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 17, 2021
News
Bariatric surgery tied to fewer HFpEF hospitalizations
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 15, 2021
News

‘Twincretin’ meets primary endpoints in five pivotal diabetes trials
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 14, 2021
News

Mavacamten boosts quality of life in patients with hypertrophic cardiomyopathy
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 4, 2021
News

Dapagliflozin’s cost-effectiveness ‘intermediate’ for HFrEF
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 3, 2021
News
Prediabetes linked to higher CVD and CKD rates
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 2, 2021
News

Rivaroxaban cut recurrent limb events in VOYAGER-PAD
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 26, 2021
News

Sotagliflozin’s HFpEF benefit confirmed by new analyses
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 24, 2021
News

FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 18, 2021
News

Ultrasound renal denervation drops BP in patients on triple therapy
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 16, 2021
News

PARADISE-MI: Sacubitril/valsartan can’t beat ramipril in patients with acute MI
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 15, 2021
News
FDA blazes path for ‘real-world’ evidence as proof of efficacy
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 11, 2021
News
Finerenone scores second pivotal-trial success in patients with diabetic kidney disease
- Author:
- Mitchel L. Zoler, PhD
Publish date: May 10, 2021